Michael R. Vasko - Publications

Affiliations: 
Indiana University School of Medicine, Indianapolis, IN, United States 
Area:
pain, pharmacology, signaling pathways

65/124 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Iadarola MJ, Sapio MR, Loydpierson AJ, Mervis CB, Fehrenbacher JC, Vasko MR, Maric D, Eisenberg DP, Nash TA, Kippenhan JS, Garvey MH, Mannes AJ, Gregory MD, Berman KF. Syntaxin1A overexpression and pain insensitivity in individuals with 7q11.23 duplication syndrome. Jci Insight. PMID 38261410 DOI: 10.1172/jci.insight.176147  0.652
2017 Fehrenbacher JC, Guo C, Kelley MR, Vasko MR. DNA damage mediates changes in neuronal sensitivity induced by the inflammatory mediators, MCP-1 and LPS, and can be reversed by enhancing the DNA repair function of APE1. Neuroscience. PMID 28965839 DOI: 10.1016/J.Neuroscience.2017.09.039  0.732
2017 Ramsden CE, Domenichiello AF, Yuan ZX, Sapio MR, Keyes GS, Mishra SK, Gross JR, Majchrzak-Hong S, Zamora D, Horowitz MS, Davis JM, Sorokin AV, Dey A, LaPaglia DM, Wheeler JJ, ... Vasko MR, et al. A systems approach for discovering linoleic acid derivatives that potentially mediate pain and itch. Science Signaling. 10. PMID 28831021 DOI: 10.1126/Scisignal.Aal5241  0.399
2016 Kelley MR, Wikel JH, Guo C, Pollok KE, Bailey BJ, Wireman R, Fishel ML, Vasko MR. Identification of new chemical entities targeting APE1 for the prevention of chemotherapy-induced peripheral neuropathy (CIPN). The Journal of Pharmacology and Experimental Therapeutics. PMID 27608656 DOI: 10.1124/Jpet.116.235283  0.401
2016 Malty RH, Hudmon A, Fehrenbacher JC, Vasko MR. Long-term exposure to PGE2 causes homologous desensitization of receptor-mediated activation of protein kinase A. Journal of Neuroinflammation. 13: 181. PMID 27400965 DOI: 10.1186/S12974-016-0645-0  0.706
2016 Georgiadis MM, Chen Q, Meng J, Guo C, Wireman R, Reed A, Vasko MR, Kelley MR. Small molecule activation of apurinic/apyrimidinic endonuclease 1 reduces DNA damage induced by cisplatin in cultured sensory neurons. Dna Repair. 41: 32-41. PMID 27078577 DOI: 10.1016/J.Dnarep.2016.03.009  0.449
2016 Robarge JD, Duarte DB, Shariati B, Wang R, Flockhart DA, Vasko MR. Aromatase inhibitors augment nociceptive behaviors in rats and enhance the excitability of sensory neurons. Experimental Neurology. PMID 27072527 DOI: 10.1016/j.expneurol.2016.04.006  0.494
2016 Duarte DB, Vasko MR, Fehrenbacher JC. Models of Inflammation: Carrageenan Air Pouch. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. 72: 5.6.1-9. PMID 26995549 DOI: 10.1002/0471141755.ph0506s72  0.682
2015 Shariati B, Thompson EL, Nicol GD, Vasko MR. Epac activation sensitizes rat sensory neurons via activation of ras. Molecular and Cellular Neurosciences. PMID 26596174 DOI: 10.1016/j.mcn.2015.11.005  0.5
2015 Barbosa C, Tan ZY, Wang R, Xie W, Strong JA, Patel RR, Vasko MR, Zhang JM, Cummins TR. Navβ4 regulates fast resurgent sodium currents and excitability in sensory neurons. Molecular Pain. 11: 60. PMID 26408173 DOI: 10.1186/S12990-015-0063-9  0.371
2015 Kim HS, Guo C, Thompson EL, Jiang Y, Kelley MR, Vasko MR, Lee SH. APE1, the DNA base excision repair protein, regulates the removal of platinum adducts in sensory neuronal cultures by NER. Mutation Research. 779: 96-104. PMID 26164266 DOI: 10.1016/J.Mrfmmm.2015.06.010  0.414
2014 Kelley MR, Jiang Y, Guo C, Reed A, Meng H, Vasko MR. Role of the DNA base excision repair protein, APE1 in cisplatin, oxaliplatin, or carboplatin induced sensory neuropathy. Plos One. 9: e106485. PMID 25188410 DOI: 10.1371/Journal.Pone.0106485  0.456
2014 Vasko MR, Habashy Malty R, Guo C, Duarte DB, Zhang Y, Nicol GD. Nerve growth factor mediates a switch in intracellular signaling for PGE2-induced sensitization of sensory neurons from protein kinase A to Epac. Plos One. 9: e104529. PMID 25126967 DOI: 10.1371/journal.pone.0104529  0.535
2014 Pittman SK, Gracias NG, Vasko MR, Fehrenbacher JC. Paclitaxel alters the evoked release of calcitonin gene-related peptide from rat sensory neurons in culture. Experimental Neurology. 253: 146-53. PMID 24374060 DOI: 10.1016/J.Expneurol.2013.12.011  0.753
2012 Piekarz AD, Due MR, Khanna M, Wang B, Ripsch MS, Wang R, Meroueh SO, Vasko MR, White FA, Khanna R. CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy. Molecular Pain. 8: 54. PMID 22828369 DOI: 10.1186/1744-8069-8-54  0.364
2012 Duarte DB, Vasko MR, Fehrenbacher JC. Models of inflammation: carrageenan air pouch. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. Unit5.6. PMID 22383000 DOI: 10.1002/0471141755.ph0506s56  0.681
2012 Fehrenbacher JC, Vasko MR, Duarte DB. Models of inflammation: Carrageenan- or complete Freund's Adjuvant (CFA)-induced edema and hypersensitivity in the rat. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. Unit5.4. PMID 22382999 DOI: 10.1002/0471141755.ph0504s56  0.726
2011 Vasko MR, Guo C, Thompson EL, Kelley MR. The repair function of the multifunctional DNA repair/redox protein APE1 is neuroprotective after ionizing radiation. Dna Repair. 10: 942-52. PMID 21741887 DOI: 10.1016/J.Dnarep.2011.06.004  0.449
2011 Brittain JM, Duarte DB, Wilson SM, Zhu W, Ballard C, Johnson PL, Liu N, Xiong W, Ripsch MS, Wang Y, Fehrenbacher JC, Fitz SD, Khanna M, Park CK, Schmutzler BS, ... ... Vasko MR, et al. Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex. Nature Medicine. 17: 822-9. PMID 21642979 DOI: 10.1038/Nm.2345  0.726
2011 Duarte DB, Duan JH, Nicol GD, Vasko MR, Hingtgen CM. Reduced expression of SynGAP, a neuronal GTPase-activating protein, enhances capsaicin-induced peripheral sensitization. Journal of Neurophysiology. 106: 309-18. PMID 21525372 DOI: 10.1152/Jn.00963.2010  0.516
2011 Gracias NG, Cummins TR, Kelley MR, Basile DP, Iqbal T, Vasko MR. Vasodilatation in the rat dorsal hindpaw induced by activation of sensory neurons is reduced by paclitaxel. Neurotoxicology. 32: 140-9. PMID 20932997 DOI: 10.1016/J.Neuro.2010.09.006  0.738
2011 Khanna R, Brittain J, Duarte D, Wilson S, Zhu W, Ballard C, Johnson P, Liu N, Xiong W, Ripsch M, Wang Y, Fehrenbacher J, Khanna M, Park C, Brustovetsky N, ... ... Vasko M, et al. Suppression of inflammatory and neuropathic pain by uncoupling collapsin response mediator protein 2 (CRMP-2) from the presynaptic calcium channel complex F1000research. 2. DOI: 10.7490/F1000Research.1089589.1  0.671
2010 Park KA, Fehrenbacher JC, Thompson EL, Duarte DB, Hingtgen CM, Vasko MR. Signaling pathways that mediate nerve growth factor-induced increase in expression and release of calcitonin gene-related peptide from sensory neurons. Neuroscience. 171: 910-23. PMID 20870010 DOI: 10.1016/J.Neuroscience.2010.09.027  0.783
2009 Jiang Y, Guo C, Fishel ML, Wang ZY, Vasko MR, Kelley MR. Role of APE1 in differentiated neuroblastoma SH-SY5Y cells in response to oxidative stress: use of APE1 small molecule inhibitors to delineate APE1 functions. Dna Repair. 8: 1273-82. PMID 19726241 DOI: 10.1016/J.Dnarep.2009.08.003  0.321
2009 Khodorova A, Richter J, Vasko MR, Strichartz G. Early and late contributions of glutamate and CGRP to mechanical sensitization by endothelin-1. The Journal of Pain : Official Journal of the American Pain Society. 10: 740-9. PMID 19559390 DOI: 10.1016/j.jpain.2009.01.265  0.383
2009 Shrestha S, Gracias NG, Mujenda F, Khodorova A, Vasko MR, Strichartz GR. Local antinociception induced by endothelin-1 in the hairy skin of the rat's back. The Journal of Pain : Official Journal of the American Pain Society. 10: 702-14. PMID 19559389 DOI: 10.1016/j.jpain.2008.12.005  0.634
2009 Sun YG, Gracias NG, Drobish JK, Vasko MR, Gereau RW, Chen ZF. The c-kit signaling pathway is involved in the development of persistent pain. Pain. 144: 178-86. PMID 19443120 DOI: 10.1016/J.Pain.2009.04.011  0.651
2009 Stein C, Clark JD, Oh U, Vasko MR, Wilcox GL, Overland AC, Vanderah TW, Spencer RH. Peripheral mechanisms of pain and analgesia. Brain Research Reviews. 60: 90-113. PMID 19150465 DOI: 10.1016/J.Brainresrev.2008.12.017  0.462
2008 Jiang Y, Guo C, Vasko MR, Kelley MR. Implications of apurinic/apyrimidinic endonuclease in reactive oxygen signaling response after cisplatin treatment of dorsal root ganglion neurons. Cancer Research. 68: 6425-34. PMID 18676868 DOI: 10.1158/0008-5472.Can-08-1173  0.457
2008 Nazarian A, Gu G, Gracias NG, Wilkinson K, Hua XY, Vasko MR, Yaksh TL. Spinal N-methyl-D-aspartate receptors and nociception-evoked release of primary afferent substance P. Neuroscience. 152: 119-27. PMID 18222611 DOI: 10.1016/j.neuroscience.2007.11.037  0.665
2007 Nicol GD, Vasko MR. Unraveling the story of NGF-mediated sensitization of nociceptive sensory neurons: ON or OFF the Trks? Molecular Interventions. 7: 26-41. PMID 17339604 DOI: 10.1124/mi.7.1.6  0.424
2007 Fishel ML, Vasko MR, Kelley MR. DNA repair in neurons: so if they don't divide what's to repair? Mutation Research. 614: 24-36. PMID 16879837 DOI: 10.1016/J.Mrfmmm.2006.06.007  0.317
2006 Zhang YH, Fehrenbacher JC, Vasko MR, Nicol GD. Sphingosine-1-phosphate via activation of a G-protein-coupled receptor(s) enhances the excitability of rat sensory neurons. Journal of Neurophysiology. 96: 1042-52. PMID 16723416 DOI: 10.1152/jn.00120.2006  0.723
2005 Park KA, Vasko MR. Lipid mediators of sensitivity in sensory neurons. Trends in Pharmacological Sciences. 26: 571-7. PMID 16185776 DOI: 10.1016/J.Tips.2005.09.010  0.699
2005 Vasko MR, Guo C, Kelley MR. The multifunctional DNA repair/redox enzyme Ape1/Ref-1 promotes survival of neurons after oxidative stress. Dna Repair. 4: 367-79. PMID 15661660 DOI: 10.1016/J.Dnarep.2004.11.006  0.429
2005 Fehrenbacher JC, Burkey TH, Nicol GD, Vasko MR. Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells. Pain. 113: 113-22. PMID 15621371 DOI: 10.1016/j.pain.2004.09.031  0.671
2004 Burkey TH, Hingtgen CM, Vasko MR. Isolation and culture of sensory neurons from the dorsal-root ganglia of embryonic or adult rats. Methods in Molecular Medicine. 99: 189-202. PMID 15131338 DOI: 10.1385/1-59259-770-X:055  0.509
2003 Fehrenbacher JC, Taylor CP, Vasko MR. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain. 105: 133-41. PMID 14499429 DOI: 10.1016/S0304-3959(03)00173-8  0.723
2003 Huang H, Wu X, Nicol GD, Meller S, Vasko MR. ATP augments peptide release from rat sensory neurons in culture through activation of P2Y receptors. The Journal of Pharmacology and Experimental Therapeutics. 306: 1137-44. PMID 12829729 DOI: 10.1124/jpet.103.052951  0.53
2002 Zhang YH, Vasko MR, Nicol GD. Ceramide, a putative second messenger for nerve growth factor, modulates the TTX-resistant Na(+) current and delayed rectifier K(+) current in rat sensory neurons. The Journal of Physiology. 544: 385-402. PMID 12381813 DOI: 10.1113/jphysiol.2002.024265  0.338
2002 Richardson JD, Vasko MR. Cellular mechanisms of neurogenic inflammation. The Journal of Pharmacology and Experimental Therapeutics. 302: 839-45. PMID 12183638 DOI: 10.1124/jpet.102.032797  0.534
2002 Southall MD, Bolyard LA, Vasko MR. Twenty-four hour exposure to prostaglandin downregulates prostanoid receptor binding but does not alter PGE(2)-mediated sensitization of rat sensory neurons. Pain. 96: 285-96. PMID 11973001 DOI: 10.1016/S0304-3959(01)00458-4  0.734
2002 Wang X, Butowt R, Vasko MR, von Bartheld CS. Mechanisms of the release of anterogradely transported neurotrophin-3 from axon terminals. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 931-45. PMID 11826122 DOI: 10.1523/Jneurosci.22-03-00931.2002  0.349
2001 Southall MD, Vasko MR. Prostaglandin receptor subtypes, EP3C and EP4, mediate the prostaglandin E2-induced cAMP production and sensitization of sensory neurons. The Journal of Biological Chemistry. 276: 16083-91. PMID 11278900 DOI: 10.1074/Jbc.M011408200  0.699
2000 Bolyard LA, Van Looy JW, Vasko MR. Sensitization of rat sensory neurons by chronic exposure to forskolin or 'inflammatory cocktail' does not downregulate and requires continuous exposure. Pain. 88: 277-85. PMID 11068115 DOI: 10.1016/S0304-3959(00)00341-9  0.574
2000 Evans AR, Junger H, Southall MD, Nicol GD, Sorkin LS, Broome JT, Bailey TW, Vasko MR. Isoprostanes, novel eicosanoids that produce nociception and sensitize rat sensory neurons. The Journal of Pharmacology and Experimental Therapeutics. 293: 912-20. PMID 10869392  0.731
2000 Southall MD, Vasko MR. Prostaglandin E(2)-mediated sensitization of rat sensory neurons is not altered by nerve growth factor. Neuroscience Letters. 287: 33-6. PMID 10841984 DOI: 10.1016/S0304-3940(00)01158-7  0.73
1999 Frayer SM, Barber LA, Vasko MR. Activation of protein kinase C enhances peptide release from rat spinal cord slices. Neuroscience Letters. 265: 17-20. PMID 10327195 DOI: 10.1016/S0304-3940(99)00090-7  0.44
1999 Evans AR, Vasko MR, Nicol GD. The cAMP transduction cascade mediates the PGE2-induced inhibition of potassium currents in rat sensory neurones. The Journal of Physiology. 516: 163-78. PMID 10066931  0.312
1998 Southall MD, Michael RL, Vasko MR. Intrathecal NSAIDS attenuate inflammation-induced neuropeptide release from rat spinal cord slices. Pain. 78: 39-48. PMID 9822210 DOI: 10.1016/S0304-3959(98)00113-4  0.725
1997 Chen JJ, Dymshitz J, Vasko MR. Regulation of opioid receptors in rat sensory neurons in culture. Molecular Pharmacology. 51: 666-73. PMID 9106633 DOI: 10.1124/Mol.51.4.666  0.382
1996 Chen JJ, Barber LA, Dymshitz J, Vasko MR. Peptidase inhibitors improve recovery of substance P and calcitonin gene-related peptide release from rat spinal cord slices. Peptides. 17: 31-7. PMID 8822507 DOI: 10.1016/0196-9781(95)02091-8  0.406
1996 Evans AR, Nicol GD, Vasko MR. Differential regulation of evoked peptide release by voltage-sensitive calcium channels in rat sensory neurons. Brain Research. 712: 265-73. PMID 8814901 DOI: 10.1016/0006-8993(95)01447-0  0.471
1996 Barber LA, Vasko MR. Activation of protein kinase C augments peptide release from rat sensory neurons. Journal of Neurochemistry. 67: 72-80. PMID 8667028 DOI: 10.1046/J.1471-4159.1996.67010072.X  0.488
1995 Vasko MR. Prostaglandin-induced neuropeptide release from spinal cord. Progress in Brain Research. 104: 367-80. PMID 8552780  0.444
1995 Hingtgen CM, Waite KJ, Vasko MR. Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3',5'-cyclic monophosphate transduction cascade. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 5411-9. PMID 7623163  0.446
1994 Dymshitz J, Vasko MR. Nitric oxide and cyclic guanosine 3',5'-monophosphate do not alter neuropeptide release from rat sensory neurons grown in culture. Neuroscience. 62: 1279-86. PMID 7531304 DOI: 10.1016/0306-4522(94)90359-X  0.484
1994 Hingtgen CM, Vasko MR. The phosphatase inhibitor, okadaic acid, increases peptide release from rat sensory neurons in culture. Neuroscience Letters. 178: 135-8. PMID 7529384 DOI: 10.1016/0304-3940(94)90308-5  0.508
1994 Hingtgen CM, Vasko MR. Prostacyclin enhances the evoked-release of substance P and calcitonin gene-related peptide from rat sensory neurons. Brain Research. 655: 51-60. PMID 7529126 DOI: 10.1016/0006-8993(94)91596-2  0.524
1994 Vasko MR, Campbell WB, Waite KJ. Prostaglandin E2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 4987-97. PMID 7519258 DOI: 10.1523/Jneurosci.14-08-04987.1994  0.542
1994 Dymshitz J, Vasko MR. Endothelin-1 enhances capsaicin-induced peptide release and cGMP accumulation in cultures of rat sensory neurons. Neuroscience Letters. 167: 128-32. PMID 7513837 DOI: 10.1016/0304-3940(94)91044-8  0.476
1992 Nicol GD, Klingberg DK, Vasko MR. Prostaglandin E2 increases calcium conductance and stimulates release of substance P in avian sensory neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 12: 1917-27. PMID 1374463 DOI: 10.1523/Jneurosci.12-05-01917.1992  0.494
1991 Simon JR, Yu H, Richter JA, Vasko MR, Ghetti B. In vitro release of endogenous dopamine from the striatum of the weaver mutant mouse. Journal of Neurochemistry. 57: 1478-82. PMID 1919570 DOI: 10.1111/J.1471-4159.1991.Tb06341.X  0.323
1990 Vasko MR, Harris V. gamma-Aminobutyric acid inhibits the potassium-stimulated release of somatostatin from rat spinal cord slices. Brain Research. 507: 129-37. PMID 1967972 DOI: 10.1016/0006-8993(90)90531-F  0.383
1990 Vasko MR, Ono H. Adenosine analogs do not inhibit the potassium-stimulated release of substance P from rat spinal cord slices. Naunyn-Schmiedeberg's Archives of Pharmacology. 342: 441-6. PMID 1701522 DOI: 10.1007/BF00169462  0.393
Low-probability matches (unlikely to be authored by this person)
1997 Nicol GD, Vasko MR, Evans AR. Prostaglandins suppress an outward potassium current in embryonic rat sensory neurons. Journal of Neurophysiology. 77: 167-76. PMID 9120557  0.299
2011 Duan JH, Wang Y, Duarte D, Vasko MR, Nicol GD, Hingtgen CM. Ras signaling pathways mediate NGF-induced enhancement of excitability of small-diameter capsaicin-sensitive sensory neurons from wildtype but not Nf1+/- mice. Neuroscience Letters. 496: 70-4. PMID 21501659 DOI: 10.1016/j.neulet.2011.03.083  0.286
1981 Vasko MR, Vogt M. Regional differences in the development of tolerance to the action of morphine on 5-hydroxytryptamine containing neurons in the rat Journal of Physiology. 37p-38p.  0.273
1998 Chen JJ, Vasko MR, Wu X, Staeva TP, Baez M, Zgombick JM, Nelson DL. Multiple subtypes of serotonin receptors are expressed in rat sensory neurons in culture. The Journal of Pharmacology and Experimental Therapeutics. 287: 1119-27. PMID 9864301  0.267
2015 Kim HS, Guo C, Thompson EL, Jiang Y, Kelley MR, Vasko MR, Lee SH. APE1, the DNA base excision repair protein, regulates the removal of platinum adducts in sensory neuronal cultures by NER Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 779: 96-104. DOI: 10.1016/j.mrfmmm.2015.06.010  0.266
2008 Rimmerman N, Bradshaw HB, Hughes HV, Chen JS, Hu SS, McHugh D, Vefring E, Jahnsen JA, Thompson EL, Masuda K, Cravatt BF, Burstein S, Vasko MR, Prieto AL, O'Dell DK, et al. N-palmitoyl glycine, a novel endogenous lipid that acts as a modulator of calcium influx and nitric oxide production in sensory neurons. Molecular Pharmacology. 74: 213-24. PMID 18424551 DOI: 10.1124/Mol.108.045997  0.263
2006 Zhang YH, Vasko MR, Nicol GD. Intracellular sphingosine 1-phosphate mediates the increased excitability produced by nerve growth factor in rat sensory neurons. The Journal of Physiology. 575: 101-13. PMID 16740613 DOI: 10.1113/jphysiol.2006.111575  0.255
1986 Pang IH, Vasko MR. Morphine and norepinephrine but not 5-hydroxytryptamine and gamma-aminobutyric acid inhibit the potassium-stimulated release of substance P from rat spinal cord slices. Brain Research. 376: 268-79. PMID 2425894 DOI: 10.1016/0006-8993(86)90189-7  0.248
1991 Ono H, Mishima A, Ono S, Fukuda H, Vasko MR. Inhibitory effects of clonidine and tizanidine on release of substance P from slices of rat spinal cord and antagonism by alpha-adrenergic receptor antagonists. Neuropharmacology. 30: 585-9. PMID 1717870 DOI: 10.1016/0028-3908(91)90077-O  0.24
1981 Vasko MR, Vogt M. Site of interaction between morphine and 5-hydroxytryptamine-containing neurones in the rat brain British Journal of Pharmacology. 73: 245P-246P.  0.23
1985 Burton ME, Vasko MR, Brater DC. Comparison of drug dosing methods. Clinical Pharmacokinetics. 10: 1-37. PMID 3882303 DOI: 10.2165/00003088-198510010-00001  0.23
1990 Vasko MR. Interactions between the clinical laboratory and clinical pharmacologists to optimize drug therapy Laboratory Medicine. 21: 415-422. DOI: 10.1093/Labmed/21.7.415  0.22
1993 Vasko MR, Zirkelbach SL, Waite KJ. Prostaglandins stimulate the release of substance P from rat spinal cord slices Progress in Pharmacology and Clinical Pharmacology. 10: 69-89.  0.22
1984 Pang IH, Vasko MR. Morphine and norepinephrine but not 5-hydroxytryptamine inhibit substance P release from rat spinal cord slices Federation Proceedings. 43: no. 3768.  0.212
1985 Vasko MR, Cartwright DB, Knochel JP, Nixon JV, Brater DC. Furosemide absorption altered in decompensated congestive heart failure. Annals of Internal Medicine. 102: 314-8. PMID 3970471 DOI: 10.7326/0003-4819-102-3-314  0.209
1985 Baetens D, Vasko M, Unger RH, Orci L. Ultrastructural detection of granulated cells in the autonomic ganglia of the rat pancreas Diabetologia. 28: 841-846. PMID 3002889 DOI: 10.1007/BF00291075  0.204
1991 Burton ME, Ash CL, Hill DP, Handy T, Shepherd MD, Vasko MR. A controlled trial of the cost benefit of computerized bayesian aminoglycoside administration. Clinical Pharmacology and Therapeutics. 49: 685-94. PMID 1905602 DOI: 10.1038/Clpt.1991.86  0.199
1989 Burton ME, Gentle DL, Vasko MR. Evaluation of a Bayesian method for predicting vancomycin dosing. Dicp : the Annals of Pharmacotherapy. 23: 294-300. PMID 2728513 DOI: 10.1177/106002808902300404  0.197
2010 Flores CM, Vasko MR. The deorphanization of TRPV1 and the emergence of octadecadienoids as a new class of lipid transmitters. Molecular Interventions. 10: 137-40. PMID 20539032 DOI: 10.1124/mi.10.3.4  0.196
1984 Vasko MR, Pang IH, Vogt M. Involvement of 5-hydroxytryptamine-containing neurons in antinociception produced by injection of morphine into nucleus raphe magnus or onto spinal cord. Brain Research. 306: 341-8. PMID 6547871 DOI: 10.1016/0006-8993(84)90384-6  0.19
1986 Pang IH, Vasko MR. Effect of depletion of spinal cord norepinephrine on morphine-induced antinociception. Brain Research. 371: 171-6. PMID 3754781 DOI: 10.1016/0006-8993(86)90824-3  0.184
1987 Tominaga M, Maruyama H, Vasko MR, Baetens D, Orci L, Unger RH. Morphologic and functional changes in sympathetic nerve relationships with pancreatic alpha-cells after destruction of beta-cells in rats. Diabetes. 36: 365-73. PMID 3542658  0.17
1985 Hisatomi A, Maruyama H, Orci L, Vasko M, Unger RH. Adrenergically mediated intrapancreatic control of the glucagon response to glucopenia in the isolated rat pancreas Journal of Clinical Investigation. 75: 420-426. PMID 2857731  0.16
1978 Vasko MR, Domino EF. Tolerance development to the biphasic effects of morphine on locomotor activity and brain acetylcholine in the rat. The Journal of Pharmacology and Experimental Therapeutics. 207: 848-58. PMID 731435  0.148
1982 Vasko MR, Vogt M. Analgesia, development of tolerance, and 5-hydroxytryptamine turnover in the rat after cerebral and systemic administration of morphine. Neuroscience. 7: 1215-25. PMID 6180353 DOI: 10.1016/0306-4522(82)91128-9  0.143
1999 Vasko M, Gebhart J. Meeting report for the ASPET-Ray Fuller Symposium: Cellular mechanisms and novel strategies for pain control Journal of Pharmacology and Experimental Therapeutics. 291: 1387-1388. PMID 10565865  0.123
1984 Vaško M, Romanov A. Acta Polymerica. 35: 600-603. DOI: 10.1002/actp.1984.010350907  0.12
1979 Vaško M, Romanov A. Acta Polymerica. 30: 486-489. DOI: 10.1002/ACTP.1979.010300805  0.12
1990 Florio SK, Westbrook CD, Vasko MR, Bauer RJ, Kenyon JL. Transient potassium currents in avian sensory neurons. Journal of Neurophysiology. 63: 725-37. PMID 2341871  0.12
1974 Vasko MR, Domino EF. Biphasic effects of morphine of locomotor activity and brain acetylcholine utilization in non tolerant rats Pharmacologist. 16: 076.  0.114
1979 Carney JM, Rosecrans JA, Vasko MR. Barbitone-induced tolerance to the effects of sedative-hypnotics and related compounds on operant behaviour in the rat. British Journal of Pharmacology. 65: 183-92. PMID 760896 DOI: 10.1111/j.1476-5381.1979.tb07817.x  0.112
1981 Vasko MR, Vogt M, Fan SK. Attenuation of morphine-induced increase in 5-hydroxytryptamine turnover by aminooxyacetic acid Federation Proceedings. 40: 254.  0.111
1978 Allen CN, Perry J, Vasko MR, Crawford IL. Dipropylacetic acid does not alter cholinergic parameters in the hippocampus of the rat Pharmacologist. 20: No. 87.  0.106
2022 Vittal R, Fisher AJ, Thompson EL, Cipolla EM, Gu H, Mickler EA, Varre A, Agarwal M, Kim KK, Vasko MR, Moore BB, Lama VN. Overexpression of Decay Accelerating Factor Mitigates Fibrotic Responses to Lung Injury. American Journal of Respiratory Cell and Molecular Biology. PMID 35895592 DOI: 10.1165/rcmb.2021-0463OC  0.104
2008 Chiyo M, Iwata T, Webb TJ, Vasko MR, Thompson EL, Heidler KM, Cummings OW, Yoshida S, Fujisawa T, Brand DD, Wilkes DS. Silencing S1P1 receptors regulates collagen-V reactive lymphocyte-mediated immunobiology in the transplanted lung. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 8: 537-46. PMID 18294150 DOI: 10.1111/J.1600-6143.2007.02116.X  0.099
2006 Vasko MR, Guo C, Jiang YL, Kelley MR. 5 Enhancing the Expression of the Dna Repair/Redox Enzyme, Ape1/Ref-1, Reduces Neurotoxicity Induced by Ionizing Radiation: Implications for Decreasing Pediatric Neurocognitive Dysfunction. Pediatric Research. 60: 491-491. DOI: 10.1203/00006450-200610000-00027  0.092
1981 Galosy RA, Clarke LK, Vasko MR, Crawford IL. Neurophysiology and neuropharmacology of cardiovascular regulation and stress. Neuroscience and Biobehavioral Reviews. 5: 137-75. PMID 7015187 DOI: 10.1016/0149-7634(81)90040-3  0.092
1976 Domino EF, Vasko MR, Wilson AE. Mixed depressant and stimulant actions of morphine and their relationship to brain acetylcholine. Life Sciences. 18: 361-76. PMID 768683  0.087
1973 Vasko MR, Hug CC. Is the uptake of narcotic analgesics by cerebral cortical slices mediated in part by active transport? The Journal of Pharmacy and Pharmacology. 25: 180-3. PMID 4124625 DOI: 10.1111/j.2042-7158.1973.tb10618.x  0.082
1979 Homan RW, Vasko M. Dose-response characteristics of paroxysmal kinesigenic choreoathetosis treated with phenytoin Clinical Research. 27: 233A.  0.077
1974 Vasko MR, Domino LE, Domino EF. Differential effects of d-amphetamine on brain acetylcholine in young, adult and geriatric rats. European Journal of Pharmacology. 27: 145-7. PMID 4851386 DOI: 10.1016/0014-2999(74)90212-X  0.077
1986 Blair AJ, Richardson CT, Vasko M, Walsh JH, Feldman M. Comparison of acid secretory responsiveness to gastrin heptadecapeptide and of gastrin heptadecapeptide pharmacokinetics in duodenal ulcer patients and normal subjects Journal of Clinical Investigation. 78: 779-783. PMID 3745438  0.072
1974 Lazo JS, Vasko MR, Ruddon RW. Morphological differentiation and acetylcholine content in neuroblastoma cells Pharmacologist. 16: 330.  0.067
1979 Bell RD, Pak CY, Zerwekh J, Barilla DE, Vasko M. Effect of phenytoin on bone and vitamin D metabolism. Annals of Neurology. 5: 374-8. PMID 220903 DOI: 10.1002/ana.410050411  0.067
2012 Duarte DB, Vasko MR. The Role of DNA Damage and Repair in Neurotoxicity Caused by Cancer Therapies Dna Repair in Cancer Therapy. 283-299. DOI: 10.1016/B978-0-12-384999-1.10013-7  0.065
1979 Walker JE, Homan RW, Vasko MR, Crawford IL, Bell RD, Tasker WG. Lorazepam in status epilepticus. Annals of Neurology. 6: 207-13. PMID 43112 DOI: 10.1002/ana.410060305  0.058
1984 Sobczak PM, Hawkins CW, Vasko MR. Improvement in drug utilization in an ambulatory care setting by the use of drug profiles for physicians. Hospital Pharmacy. 19: 98-9, 103-4, 107. PMID 10265307  0.057
1985 Burton ME, Brater DC, Chen PS, Day RB, Huber PJ, Vasko MR. A Bayesian feedback method of aminoglycoside dosing. Clinical Pharmacology and Therapeutics. 37: 349-57. PMID 3971658  0.052
1980 Homan RW, Vasko MR, Blaw M. Phenytoin plasma concentrations in paroxysmal kinesigenic choreoathetosis. Neurology. 30: 673-6. PMID 7189844  0.051
1985 Brater DC, Vasko MR. Update of cardiovascular drug interactions. Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progrã¨S Des Recherches Pharmaceutiques. 29: 9-47. PMID 3911265  0.049
1974 Vasko MR, Lutz MP, Domino EF. Structure activity relations of some indolealkylamines in comparison to phenethylamines on motor activity and acquisition of avoidance behavior. Psychopharmacologia. 36: 49-58. PMID 4525044 DOI: 10.1007/BF00441381  0.049
1989 Privitera MD, Homan RW, Ludden TM, Peck CC, Vasko MR. Clinical utility of a Bayesian dosing program for phenytoin. Therapeutic Drug Monitoring. 11: 285-94. PMID 2728087  0.045
1986 Burton ME, Chow MS, Platt DR, Day RB, Brater DC, Vasko MR. Accuracy of Bayesian and Sawchuk-Zaske dosing methods for gentamicin. Clinical Pharmacy. 5: 143-9. PMID 3754192  0.044
1984 Nigam SK, Burton ME, Vasko MR. Quinidine-induced digoxin toxicity after discontinuing digoxin in a patient with renal failure. Clinical Pharmacy. 3: 662-4. PMID 6509882  0.038
1977 Hultquist DE, Vasko MR, Gray RH. The use of filtration techniques for the lysis and study of red blood cells. American Journal of Hematology. 3: 237-44. PMID 602939  0.028
1979 Vasko MR, Crawford IL. Regional distribution of brain acetylcholine in developing rabbit Federation Proceedings. 38: No. 1073.  0.025
1976 Vaško M, Bleha T, Romanov A. Thermoelasticity in Open Systems Journal of Macromolecular Science, Part C: Polymer Reviews. 15: 1-28. DOI: 10.1080/15321797608065774  0.018
1980 Vasko MR, Bell RD, Daly DD, Pippenger CE. Inheritance of phenytoin hypometabolism: a kinetic study of one family. Clinical Pharmacology and Therapeutics. 27: 96-103. PMID 7351122  0.015
1996 Lo B, Rothenberg KH, Vasko M. Physician-assisted suicide in context: constitutional, regulatory, and professional challenges The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics. 24: 181-182. PMID 9069843  0.01
Hide low-probability matches.